[go: up one dir, main page]

MXPA03000823A - Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene. - Google Patents

Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene.

Info

Publication number
MXPA03000823A
MXPA03000823A MXPA03000823A MXPA03000823A MXPA03000823A MX PA03000823 A MXPA03000823 A MX PA03000823A MX PA03000823 A MXPA03000823 A MX PA03000823A MX PA03000823 A MXPA03000823 A MX PA03000823A MX PA03000823 A MXPA03000823 A MX PA03000823A
Authority
MX
Mexico
Prior art keywords
vaccines
immediate early
early gene
herpesvirus type
equine herpesvirus
Prior art date
Application number
MXPA03000823A
Other languages
Spanish (es)
Inventor
Dennis J O'callaghan
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Publication of MXPA03000823A publication Critical patent/MXPA03000823A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
MXPA03000823A 2000-07-27 2001-07-27 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene. MXPA03000823A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62674800A 2000-07-27 2000-07-27
PCT/US2001/023612 WO2002009750A2 (en) 2000-07-27 2001-07-27 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene

Publications (1)

Publication Number Publication Date
MXPA03000823A true MXPA03000823A (en) 2003-09-10

Family

ID=24511676

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000823A MXPA03000823A (en) 2000-07-27 2001-07-27 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene.

Country Status (9)

Country Link
EP (1) EP1317481A2 (en)
JP (1) JP2004512826A (en)
AR (1) AR031599A1 (en)
AU (1) AU2001282997A1 (en)
CA (1) CA2417340A1 (en)
DE (1) DE01961753T1 (en)
MX (1) MXPA03000823A (en)
NZ (1) NZ523772A (en)
WO (1) WO2002009750A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129722A1 (en) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh gM-negative EHV-mutants
AR040601A1 (en) 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed GM NEGATIVE EHV MUTANTS WITHOUT HETEROLOGICAL ELEMENTS
AU2003251356A1 (en) * 2002-07-26 2004-02-16 Animal Health Trust Viral marker
BR112014023414B1 (en) * 2012-03-20 2022-08-30 Boehringer Ingelheim Animal Health USA Inc. RECOMBINANT EQUINE HERPESVIRUS-1 VACCINE CONTAINING A MUTANT C GLYCOPROTEIN AND ITS USES
CN108315487B (en) * 2018-04-16 2021-06-22 福建省农业科学院生物技术研究所 Primer group and kit for detecting eel herpesvirus and application of primer group and kit
CN110885794A (en) * 2019-10-30 2020-03-17 新疆农业大学 Equine herpesvirus type 1 and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292653A (en) * 1989-09-27 1994-03-08 Novagene, Inc. Equine herpesvirus 1 tk mutants
EP0668355B1 (en) * 1993-12-20 1999-04-07 Akzo Nobel N.V. Vaccine for the protection of horses against equine herpesvirus infection

Also Published As

Publication number Publication date
WO2002009750A2 (en) 2002-02-07
AU2001282997A1 (en) 2002-02-13
WO2002009750A3 (en) 2003-03-27
JP2004512826A (en) 2004-04-30
EP1317481A2 (en) 2003-06-11
AR031599A1 (en) 2003-09-24
CA2417340A1 (en) 2002-02-07
DE01961753T1 (en) 2004-03-11
NZ523772A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
NO20021833L (en) Draft insert for insert
ZA200201963B (en) Immunostimulatory nucleic acids.
ZA200105407B (en) Taste-Masked Pharmaceutical Particles.
PL351486A1 (en) Prrsv vaccines
MXPA03002906A (en) Heater device for active substances.
NO20013662L (en) Disposable bottle with gradually compressible design of the sidewalls, designed for reuse
MXPA01012478A (en) Improved pharmaceutical formulations.
AU3840101A (en) Cold-adapted equine influenza viruses
ZA200300743B (en) DDS compound and process for the preparation thereof.
ZA992478B (en) Adjuvant-containing dna vaccines.
GB9901254D0 (en) Vaccines
PT1372712E (en) Equine herpesvirus vaccine
MXPA03000823A (en) Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene.
HUP0203974A3 (en) Improved dna vaccines for production-type animals
AU1738201A (en) Adjuvants for nucleic acid vaccines
ZA200205470B (en) Virus strains for the oncolytic treatment of cancer.
HUP0203848A3 (en) Nucleic acid vaccination
MXPA01010701A (en) Vaccine.
GB2367230B (en) Baffle arrangement for animal feeder or the like
HUP0202389A3 (en) Inactivated vaccine against feline calicivirus disease
AU1674200A (en) Dna vaccine against infectious bursal disease virus
ZA200004517B (en) Cartridge for Setting Apparatuses.
AU3462900A (en) Pillow the cervical for health
AU2001251761A1 (en) Equine protozoal myeloencephalitis vaccine
MXPA01003195A (en) Carbohydrate vaccines for viral diseases.